This method bypasses the digestive system, making it ideal for people who: Have trouble absorbing B12 due to gastrointestinal issues (like Crohns disease or coeliac disease) Are on medications that interfere with B12 absorption (like metformin or anti-acids) Follow vegan or vegetarian diets Have undergone gastric surgery
Typically, injections are administered 23 times per week initially, followed by maintenance doses
But there are meaningful differences between them that are worth understanding, and the human study data tells a more nuanced story than a lot of the marketing around these peptides suggests
No peer-reviewed clinical trials have evaluated the combined use of lipotropic injections and tirzepatide for weight management or metabolic outcomes
But after burning through some $50 million developing the drug, Metabolic Pharmaceuticals Pty Ltd, which owns the patent, has continued to spruik its so-called body-enhancing benefits
Subcutaneous injections arent usually very painful because they use small needles
